|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/24 | |||
| A61K 31/4184 | |||
| A61K 31/4422 | |||
| A61K 31/495 |
| (11) | Number of the document | 3463309 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17726262.3 |
| Date of filing the European patent application | 2017-05-24 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/062516 |
| Date | 2017-05-24 |
| (87) | Number | WO 2017/207375 |
| Date | 2017-12-07 |
| (30) | Number | Date | Country code |
| 16171934 | 2016-05-30 | EP |
| (72) |
NAKATANI, Manabu, DE
SEKI, Noriko, DE
YOKOYAMA, Kazutoshi, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | FIXED DOSE COMBINATION OF TELMISARTAN, HYDROCHLOROTHIAZIDE AND AMLODIPINE |
| FIXED DOSE COMBINATION OF TELMISARTAN, HYDROCHLOROTHIAZIDE AND AMLODIPINE |